Tesamorelin/Ipamorelin Blend
$100.00
For Research Use Only. Not for human or animal use.
Product laboratory reports
Published reports linked to this product. Consult the original certificate for the reported methods and scope.
Latest linked report
Janoshik Analytical
Analysis date
2026-05-14
Sample received
2026-05-11
Recorded analysis
Recorded values; see the original report for methods and qualifiers.
Net peptide content
Ipamorelin: 3.62 mg; Tesamorelin: 14.95 mg
Identity
Ipamorelin; Tesamorelin
Earlier published reports
Open an earlier linked certificate to inspect its lot, date and recorded results.
Tesa:ipa Blend COA — 2026-03-11
Janoshik Analytical
Lot
T31948
Analysis date
2026-03-11
Net peptide content
Ipamorelin: 2.38 mg; Tesamorelin: 12.19 mg
Description
Intended strictly for research purposes only.
This research compound is provided in lyophilized form and packaged in a 3ml vial to ensure stability and reliable handling. Tesamorelin/Ipamorelin Blend is prepared for research settings that require precise materials for controlled studies.
-
Supplied as lyophilized powder for extended stability
-
Tesamorelin 15mg / Ipamorelin 3mg
-
Packaged in a 3ml vial
-
Suitable for a variety of laboratory research studies
